NR1D2 raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2025-11-19 and is reviewed periodically as new material appears.
SR9009 is a synthetic small molecule developed as an agonist of the nuclear receptors REV-ERBα (NR1D1) and REV-ERBβ (NR1D2). These receptors help regulate circadian rhythms and metabolic gene expression. In cell and animal studies, SR9009 alters transcription of genes involved in lipid metabolism, inflammation, and mitochondrial function. It is not an approved medicine, and its pharmacological profile in humans remains largely uncharacterized. The compound is frequently discussed in the context of circadian biology and metabolic research rather than clinical use.
Preclinical reports have linked SR9009 to improved endurance and altered energy expenditure in rodents. Such findings have prompted interest in whether REV-ERB activation can influence skeletal muscle metabolism. However, the reported effects depend on dose, route, and experimental model, and replication across laboratories is limited. Human trials have not established comparable outcomes, so claims about exercise performance remain speculative. The absence of controlled human data is a central limitation in interpreting these observations.
The mechanism of action involves binding to REV-ERB receptors and recruiting corepressor complexes, which represses target gene transcription. This contrasts with many nuclear receptor agonists that activate transcription. Downstream effects may include changes in autophagy, mitochondrial biogenesis, and lipid handling, but the precise pathways remain an active area of study. Whether these molecular events translate into meaningful physiological effects in humans is unresolved. Most evidence comes from cultured cells and rodent models rather than human participants.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not a steroid, peptide, or natural hormone. In scientific literature, it appears under the code SR9009 and in non-scientific contexts as Stenabolic. The compound was identified through chemical screening efforts aimed at targeting circadian clock components. Its status remains investigational, and no regulatory agency has approved it as a human medicine.
REV-ERB proteins help regulate daily cycles in gene expression, including genes tied to lipid and glucose metabolism. SR9009 binds these receptors and alters their activity in cell and animal experiments. Consequences observed in rodents include changes in skeletal muscle oxidative capacity, blood lipid levels, and exercise performance. The precise chain from receptor occupancy to whole-body effects is still an active area of study. Human responses cannot be assumed from rodent data.
Most published work on SR9009 consists of preclinical studies. It is widely sold as a research chemical, a category that does not imply safety, efficacy, or pharmaceutical-grade quality. Sports anti-doping organizations have listed SR9009 as a prohibited substance, and its presence in an athlete sample can lead to sanctions. Legal status differs by country; in several jurisdictions it is not approved for human consumption and may be treated as an unapproved new drug.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic REV-ERB agonist | Small molecule; not a steroid or peptide. |
| Primary targets | NR1D1 and NR1D2 | Also known as REV-ERBα and REV-ERBβ. |
| Studied routes | Intraperitoneal in rodents | Oral bioavailability in humans is not established. |
| Human approval | No approved therapeutic indication | No recognized clinical use. |
| Key uncertainty | Human physiological effects | Preclinical findings may not translate. |
Regulatory agencies have not approved SR9009 for human therapeutic use. It is typically sold as a research chemical with labels stating that it is not for human consumption. The World Anti-Doping Agency prohibits the substance in sport, generally under the category of non-approved substances. Customs and national laws may restrict importation, sale, or possession. Product quality and legal status can vary by country and vendor, and therapeutic claims are not permitted in regulated advertising because the compound lacks approval.
Several misconceptions surround SR9009. It is often described as a SARM, a steroid, or an exercise pill, but its known target is the REV-ERB receptor family. Rodent studies have examined exercise capacity and metabolic markers, yet human outcomes remain unproven. Oral bioavailability appears low in animals, and human pharmacokinetics are not well characterized. Online products may contain impurities or different compounds, so identity and purity testing are important for research use.
Organic molecular cages represent a unique class of porous materials characterized by their discrete molecular nature and well-defined internal cavities, formed through covalent bonds between precisely designed organic building blocks. These molecular structures contain organized frameworks surrounding a central cavity, where organic components are precisely arranged to create functional internal spaces. Unlike extended networks such as metal-organic frameworks (MOFs) and covalent organic frameworks (COFs), these cage compounds exist as distinct molecular entities, offering advantages in solution processability and structural precision.
=== Road freight === Transport by road is by far the most popular means of moving freight around South Africa. As of October 2025, over 85% of land freight in SA travels by road. For every ton of freight moved by rail, more than six tons is moved by road. Each year, almost 1 billion tons (984 million) of freight is transported along South Africa's road networks. This is an increase of over 50% over the period between 2010 and 2025. National roads in South Africa are administered by SANRAL, a state-owned company that reports to the Department of Transport. SANRAL is responsible for financing, managing, planning, developing, and maintaining the national road network. Municipalities also have control over and put funding into certain roadways. Certain avenues of private funding for roadways in South Africa also exist.
During his visit to Colombia, Pope Francis brought with him a message of peace and paid tribute to the victims of the conflict. The Special Jurisdiction of Peace (Jurisdicción Especial para la Paz, JEP) is the transitional justice component of the Comprehensive System, complying with Colombia's duty to investigate, clarify, prosecute, and punish serious human rights violations and grave breaches of international humanitarian law which occurred during the armed conflict. Its objectives are to satisfy victims' right to justice, offer truth to the public, contribute to the reparation of victims, contribute to the fight against impunity, and adopt decisions which give full legal security to direct and indirect participants in the conflict and contribute to the achievement of a stable and lasting peace. The Special Unit for the Search of Missing Persons in the context and due to the armed conflict (Unidad especial para la búsqueda de personas dadas por desaparecidas en el contexto y en razón del conflicto armado) would be a special high-level unit created following the signature of the final agreement. It would direct and coordinate efforts to search for and locate missing persons, or find their remains so that they may be returned to their families.
Sources: en.wikipedia.org
== Career and research == While a graduate student at the University of Iowa, Sherman also worked in the campus library and as a janitor in addition to his research assistant duties. In 1953, while working as a research associate in the university's Department of Urology, Sherman refined a process that had been developed in 1949 by A.S. Parkes and two British scientists, which involved the use of glycerol to preserve animal sperm during freezing and thawing. Combined with the glycerol method, Sherman introduced slow cooling and use of solid carbon dioxide as a refrigerant during storage. Sherman collaborated on these experiments with urologist Dr. Raymond Bunge, who arranged for Sherman to be hired in the urology department and who was affiliated with the university's new fertility clinic, which had opened in early 1952. Bunge and Sherman had met while Sherman was painting the former's house in another side job. In 1953, three patients at the clinic were impregnated using frozen sperm, with Dr. William Keettel, an obstetrician at the fertility clinic, overseeing the patients. The same year, Sherman established the first sperm cryobank in the world in Iowa City to assist these pregnancies. Bunge and Sherman published their findings first in the Proceedings of the Society for Experimental Biology and Medicine and later Nature magazine.
=== Brain === Brain cells also require insulin, such that insulin resistance in the brain is implicated in neurodegenerative disease. (Although insulin does not cross the blood-brain barrier natively, it can do so by carrier-mediated transport systems.)
The Bristol Brabazon was a large trans-Atlantic airliner built in the late 1940s, based on developments in heavy bombers during World War II, but it received no sales orders and never went into production. Concorde, the first supersonic airliner was built in the 1960s, first flying in 1969. The aircraft never achieved commercial success, but its development did lay the foundation for the successful Airbus series of airliners, parts of which are produced at Filton in the 21st century. In the 1980s the financial services sector became a major employer in the city and surrounding areas, such as the business parks on the northern fringe of what was now referred to as Greater Bristol or the Bristol Urban Area comprising the city, Easton-in-Gordano, Frampton Cottrell and Winterbourne, Kingswood, Mangotsfield and Stoke Gifford. High technology companies such as IBM, Hewlett Packard, Toshiba, and Orange, along with creative and media enterprises become significant local employers as traditional manufacturing industries declined. Like much of British post-war planning, regeneration of Bristol city centre was characterised by large, cheap tower blocks, brutalist architecture and expansion of roads. Since the 1990s this trend has been reversed, with the closure of some main roads and the regeneration of the Broadmead shopping centre. In 2006 one of the city centre's tallest post-war blocks was torn down. Social housing tower blocks have also been demolished to be replaced by low rise homes.
== Contraindications == Apomorphine is contraindicated when used concomitantly with serotonin 5-HT3 receptor antagonists, including ondansetron, granisetron, and palonosetron, as this combination has been associated with profound hypotension and loss of consciousness. It is also contraindicated with allergies to the drug or its excipients, including sulfites. Intravenous administration of apomorphine is associated with blood clots and pulmonary embolism due to crystallization in the vein and is not recommended.
Sources: en.wikipedia.org
Carnexiv is indicated for short-term treatment of up to seven days for partial seizures with complex symptomatology, generalized tonic–clonic seizures and mixed seizure patterns, in patients who are temporarily unable to take or tolerate oral medications. It has also been shown to improve symptoms of "typewriter tinnitus", a type of tinnitus caused by the neurovascular compression of the cochleovestibular nerve.
== Taxonomy == German naturalist Wilhelm Peters described the coastal taipan as Pseudechis scutellatus in 1867, from material collected in Rockhampton, Queensland. Charles Walter De Vis described Pseudechis wilesmithii from Walsh River in north Queensland in 1911. In 1922, scientific bird collector William McLennan killed two snakes near Coen in far north Queensland. Impressed by their size—up to 2.76 m, he sent the skins and skulls to the Australian Museum in Sydney. Australian naturalist Roy Kinghorn established the genus Oxyuranus in 1923, describing a specimen from Coen as O. maclennani after its collector. He noted the distinctness of the palatine bone necessitated the new genus as distinct from all other elapid snakes. In 1930, Kinghorn announced it as the second largest venomous snake in the world, with 3/4 inch fangs. In 1933, Australian zoologist Donald Thomson concluded that Pseudechis scutellatus and Oxyuranus maclennani were the same species; this meant that Peters' specific epithet had priority, as did Kinghorn's genus as the species was highly distinct. Hence, the coastal taipan became Oxyuranus scutellatus. Thomson had spent some years in Cape York peninsula with the indigenous people, who told tales of a giant snake they greatly feared. Australian herpetologist Ken Slater described Oxyuranus scutellatus canni, commonly known as the Papuan taipan, in 1956, on the basis of its distinctive coloration. He named it after George Cann, longtime Snake Man of La Perouse. It is found throughout the southern portion of the island of New Guinea.
General Public were an English new wave band, formed in Birmingham in 1983, by vocalists Dave Wakeling and Ranking Roger of the Beat, and which also included former members of Dexys Midnight Runners, the Specials, and the Clash. They are best remembered for their hits "Tenderness" (1984) and "I'll Take You There" (1994).
=== Similar species === In Europe, the spring-fruiting Amanita verna is a similar all-white species, as is the autumn-fruiting, white form of Amanita phalloides (deathcap). Both are equally poisonous. In their immature, button-mushroom stage, all these poisonous species could be mistaken for young, white-capped, edible mushrooms (Agaricus species), highlighting the danger of picking immature fruit bodies for food. In general, there are about 22 species that are considered destroying angels.
=== Small RNA molecules are abundant in the eukaryotic nucleus === Small nuclear RNA molecules (snRNAs) were identified in the eukaryotic nucleus using immunological studies with autoimmune antibodies, which bind to small nuclear ribonucleoprotein complexes (snRNPs; complexes of the snRNA and protein). Subsequent biochemical, genetic, and phylogenetic studies established that many of these molecules play key roles in essential RNA processing reactions within the nucleus and nucleolus, including RNA splicing, polyadenylation, and the maturation of ribosomal RNAs.
Sources: en.wikipedia.org
It is a synthetic compound that acts as an agonist at REV-ERBα and REV-ERBβ. It is used mainly as a research chemical to study circadian and metabolic pathways. It is not approved for human therapeutic use.
REV-ERB receptors generally repress transcription when bound by natural heme. SR9009 is described as an agonist that enhances this repressive activity. The result is altered expression of clock and metabolic genes.
Published controlled human trials are lacking. Some sources cite limited or unofficial reports, but these do not establish safety or efficacy. Claims about human performance effects remain unverified.
It is a synthetic compound studied as an agonist of REV-ERB nuclear receptors. It is not an approved medicine and has mainly been examined in laboratory and animal research.